Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urinary calculi formation refers to the aggregation of crystals—commonly calcium oxalate, calcium phosphate, uric acid, cystine, and struvite—that supersaturate in urine and aggregate to form solid stones within the renal parenchyma, urinary collecting system, or anywhere along the urinary tract[1][2][3][4][5][6][7]. This process can result from genetic, metabolic, dietary, or environmental factors and is the leading cause of kidney stones (nephrolithiasis/urolithiasis). Pathophysiology involves crystal nucleation, growth, and aggregation within a supersaturated urinary environment, which can be influenced by abnormalities in urine composition, pH, volume, or inhibitors of crystallization. Urinary calculi can cause pain, hematuria, infection, and urinary tract obstruction[1][2][3][4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urinary calculi formation.